Effect of nebulized ketamine on reducing pain of nasogastric tube

Phase 1

Conditions: Y84.9, Y84
Pain Management in nasogastric tube insertj.
Medical procedure, unspecified, Insertion of gastric or duodenal sound

Registration Number: IRCT201206029162N2

Lead Sponsor: Tehran University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Complete

Sex: All

Target Recruitment: 60

Inclusion Criteria

Patients admitted to emergency department of Imam Khomeini hospital which needs NG tube; Age greater than or equal to 15 years

Exclusion Criteria

inability to express the pain(eg,Altered Mental Status,Language Barrier,Dementia, intoxication); Severe Hypertension (BP> 180/110); Unstable Multiple Trauma patients (SBP < 90mmhg, GCS<14, needs operating room at time of entrance); Pregnancy (visible or declared by patient); Use of Opium in last 6 hours; Opium addiction; Coronary Artery Disease (declared by patient); Decompensated Heart failure (Rales at lungs exam); Allergy to Ketamine; Reactive Airway Diseases; Abnormal Airway Anatomy ; Nasal fracture (in last week); deformity & bleeding; Patients who doesn't sign the consent form

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain of insertion of NG Tube. Timepoint: After insertion of tube. Method of measurement: Asking the patient.;Complications of insertion of nasogastric tube. Timepoint: continuously from insertion of tube until 60 min after procedure. Method of measurement: observation of complication such as: nausea, vomiting, nose bleed, hypoxia, tracheal insertion.;Complication of drug. Timepoint: continuously from begining of the nebulization of drug until 60 min after procedure. Method of measurement: Observation of Ketamine complication such as Hallucination, Nausea, vomiting, hypertension, agitation and seizure.

Secondary Outcome Measures

Name	Time	Method
Arterial O2 Saturation. Timepoint: At the begining of the procedure until 30 min after that. Method of measurement: By pulse-oxymeter.;Heart Rate. Timepoint: At the begining of the procedure until 30 min after that. Method of measurement: By pulse-oxymeter.;Systolic BP. Timepoint: At the begining of the procedure until 30 min after that. Method of measurement: Sphygmomanometer.